Welcome to our dedicated page for Glucose Health news (Ticker: GLUC), a resource for investors and traders seeking the latest updates and insights on Glucose Health stock.
Glucose Health, Inc. (GLUC) delivers science-backed dietary supplements targeting metabolic health support, with a specific focus on pre-diabetes and type-2 diabetes management. This news hub provides investors and health industry stakeholders with timely updates on product developments, regulatory milestones, and corporate announcements.
Our comprehensive resource aggregates all official press releases and verified news coverage related to GLUC's operations. Users can expect updates spanning new product launches, distribution partnerships, financial performance, and clinical research developments. The curated content supports informed decision-making by maintaining strict adherence to factual reporting.
Key areas of coverage include innovations in the Fiber Up® product line, retail distribution expansions, and manufacturing quality initiatives. Each update is selected to reflect material developments affecting the company's position in the nutraceutical market.
Bookmark this page for direct access to primary source information about Glucose Health's mission to advance dietary solutions through natural formulations. Check regularly for updates on strategic initiatives that shape the company's role in metabolic health innovation.
Glucose Health, Inc. (OTC: GLUC) has launched a strategic media campaign across CNBC, Fox Business, and Bloomberg Television to highlight the U.S. Department of Health and Human Services' designation of dietary fiber as a "nutrient of public health concern." The campaign targets the New York City metro area to attract retail, institutional, and investment bank attention.
The company's two main brands, GlucoDown® and Fiber Up®, feature patent-pending soluble fiber formulations competing with established products like Glucerna® and Metamucil®. GlucoDown® supports balanced glucose levels, while Fiber Up® targets metabolic and digestive health. The company aims to capitalize on expected increased consumer demand following the federal designation of dietary fiber as a priority nutrient in the Dietary Guidelines for Americans, 2020-2025.
Glucose Health, Inc. (OTC: GLUC) has highlighted its long-standing commitment to using only natural colors in its GlucoDown® and Fiber Up® products, contrasting with competitors like Metamucil® who have traditionally used synthetic dyes. Since 2017, the company's products have been formulated with natural colors from vegetables like beets and carrots, avoiding artificial dyes such as Yellow 6 and Red 40.
The company emphasizes its patent-pending metabolic nutrition formulation that supports metabolic wellness, including balanced glucose and cholesterol levels. Their products contain 100% soluble dietary fiber and natural flavors, with no preservatives or fillers, positioning the company advantageously as the U.S. Department of Health and Human Services has designated dietary fiber as a nutrient of public health concern.
Glucose Health, Inc. (OTC: GLUC) highlighted the U.S. Department of Health and Human Services (HHS) and USDA's designation of dietary fiber as one of four nutrients of public health concern in their 2020-2025 Dietary Guidelines for Americans. This federal recognition validates the company's strategic focus on fiber-based nutrition products.
The company's flagship brand GlucoDown®, a dietary fiber-infused drink formulated for balanced glucose levels, competes with major brands like Glucerna® and Boost® in national pharmacy chains. Additionally, their Fiber Up® brand, utilizing a variant of their patent-pending formulation, targets digestive and gut health, competing with Metamucil®.
CEO Murray Fleming emphasized that this federal designation aligns with their core mission since 2017, positioning the company to potentially benefit from increased government funding for dietary fiber awareness campaigns and anticipated rising consumer demand.
Glucose Health, Inc. (OTC PINK:GLUC) reported strong fiscal 2022 results, achieving over $1 million in annual revenue for the first time, totaling $1,072,655, a 12% increase from $953,681 in 2021. The company also saw gross profits rise 11% to $456,715. With zero debt and minimal liabilities, GLUC continues as an emerging growth company. The successful launch of GLUCODOWN® flavors, available on Amazon and CVS, supports this growth. In 2023, Glucose Health plans to expand its distribution and launch new brands like FIBER UP® and be rite®. The company maintains a strong online and in-store presence with positive customer feedback.
FAQ
What is the current stock price of Glucose Health (GLUC)?
What is the market cap of Glucose Health (GLUC)?
